| Literature DB >> 35036907 |
Matthew Beaudet1, Léa Ravensbergen1, James DeWeese1, William Beaubien-Souligny2, Annie-Claire Nadeau-Fredette3, Norka Rios4, Marie-Line Caron5, Rita S Suri6, Ahmed El-Geneidy1.
Abstract
Transportation is a key element of access to healthcare. The COVID-19 pandemic posed unique and unforeseen challenges to patients receiving hemodialysis who rely on three times weekly transportation to receive their life-saving treatments, but there is little data on the problems they faced. This study explores the attitudes, fears, and concerns of hemodialysis patients during the pandemic with a focus on their travel to/from dialysis treatments. A mixed methods travel survey was distributed to hemodialysis patients from three urban centers in Montréal, Canada, during the pandemic (n = 43). The survey included closed questions that were analysed through descriptive statistics as well as open-ended questions that were assessed through thematic analysis. Descriptive statistics show that hemodialysis patients are more fearful of contracting COVID-19 in transit than they are at the treatment center. Patients taking paratransit, public transportation, and taxis are more fearful of COVID-19 while traveling than those who drive, who are driven, or who walk to the clinic. In the open-ended questions, patients reported struggling with confusing COVID-19 protocols in public transport, including conflicting information on whether paratransit taxis allowed one or multiple passengers. Paratransit was the most used travel mode to access treatment (n = 30), with problems identified in the open-ended questions, such as long and unreliable pickup windows, and extended travel times. To limit COVID-19 exposure and stress for paratransit users, agencies should consider sitting one patient per paratransit taxi, clearly communicating COVID-19 protocols online and in the vehicles, and tracking vehicles for more efficient pickups.Entities:
Keywords: Access to care; COVID-19; Hemodialysis; Paratransit; Transportation
Year: 2022 PMID: 35036907 PMCID: PMC8743465 DOI: 10.1016/j.trip.2021.100533
Source DB: PubMed Journal: Transp Res Interdiscip Perspect ISSN: 2590-1982
Summary statistics.
| Gender | n | % | Dialysis Clinic | n | % |
|---|---|---|---|---|---|
| Male | 27 | 64% | CHUM (clinique externe de Gaspé) | 16 | 37% |
| Female | 16 | 38% | MUHC (Lachine site) | 25 | 58% |
| MUHC (Glen Site) | 2 | 5% | |||
| 40–49 | 6 | 14% | Primary/Elementary school diploma | 4 | 9% |
| 50–59 | 11 | 26% | Secondary school diploma | 15 | 35% |
| 60–69 | 13 | 30% | Trade/Technical school or college diploma | 12 | 28% |
| 70–79 | 10 | 23% | Undergraduate degree | 2 | 5% |
| 80–89 | 2 | 5% | Graduate degree | 8 | 19% |
| 90–99 | 1 | 2% | Prefer not to answer | 1 | 2% |
| I don’t know | 1 | 2% | |||
| Excellent | 4 | 9% | Single (never married) | 11 | 26% |
| Very Good | 10 | 23% | Married (or common law partner) | 18 | 42% |
| Good | 14 | 33% | Separated or divorced | 10 | 23% |
| Fair | 14 | 33% | Prefer not to answer | 4 | 9% |
| Poor | 1 | 2% | |||
| Paratransit van or shuttle (STM, RTL, EXO, STL) | 12 | 28% | Diabetes | 22 | 51% |
| Paratransit Taxi | 18 | 42% | Arthritis | 10 | 23% |
| Taxi | 6 | 14% | Heart Disease | 8 | 19% |
| Bus (STM, RTL, EXO, STL) | 1 | 2% | Peripheral Vascular Disease/Circulation Problems | 8 | 19% |
| Metro (STM) | 2 | 5% | Stroke or Transient Ischemic Attack (TIA) | 5 | 12% |
| Passenger in a car | 3 | 7% | Cancer | 5 | 12% |
| Driver of a car | 8 | 19% | Heart Failure | 4 | 9% |
| Walk | 4 | 9% | Chronic Lung Disease, Chronic Bronchitis or Chronic Obstructive Lung Disease | 4 | 9% |
| Liver disease, Hepatitis C, or Hepatitis B | 3 | 7% | |||
Fig. 1Hemodialysis clinic locations.
Fig. 2Passenger attitudes concerning safety in paratransit.
Fig. 3Fear of contracting COVID-19 on a scale of 0 (not worried) – 10 (extremely worried) and mode of transport.
Fig. 4Responses to “The time I spend in paratransit is reasonable” and travel time (in minutes).
Fig. 5Agreement with paratransit time-related statements.